BioCorRx (BICX) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn |
| 10 | BioCorRx | - | - | 189,355.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.50% |
| Dec 31, 2025 | 12.23% |
| Sep 30, 2025 | 67.54% |
| Jun 30, 2025 | -13.28% |
| Mar 31, 2025 | 4.61% |
| Dec 31, 2024 | -0.41% |
| Sep 30, 2024 | -7.91% |
| Jun 30, 2024 | 9.57% |
| Mar 31, 2024 | -5.07% |
| Dec 31, 2023 | 7.27% |
| Sep 30, 2023 | 1.08% |
| Jun 30, 2023 | 11.51% |
| Mar 31, 2023 | -2.19% |
| Dec 31, 2022 | -15.40% |
| Sep 30, 2022 | 9.49% |
| Jun 30, 2022 | -16.23% |
| Mar 31, 2022 | 37.83% |
| Dec 31, 2021 | -22.51% |
| Sep 30, 2021 | 13.55% |
| Jun 30, 2021 | -10.80% |
| Mar 31, 2021 | -17.95% |
| Dec 31, 2020 | -12.76% |
| Sep 30, 2020 | -3.19% |
| Jun 30, 2020 | 28.57% |
| Mar 31, 2020 | -28.90% |
| Dec 31, 2019 | 9.90% |
| Sep 30, 2019 | -14.93% |
| Jun 30, 2019 | -63.50% |
| Mar 31, 2019 | 3.41% |
| Dec 31, 2018 | 18.95% |
| Sep 30, 2018 | -68.69% |
| Jun 30, 2018 | -87.45% |
| Mar 31, 2018 | -60.88% |
| Dec 31, 2017 | 194.75% |
| Sep 30, 2017 | -66.94% |
| Jun 30, 2017 | 98.34% |
| Mar 31, 2017 | -280.06% |
| Dec 31, 2016 | 50.69% |
| Sep 30, 2016 | -84.31% |
| Jun 30, 2016 | -56.57% |
| Mar 31, 2016 | -36.56% |
| Sep 30, 2015 | -172.77% |